News
Funding to study new drugs against autoimmune diseases
IDIBELL researcher Josep Maria Aran and his research group will receive 100,000 euros from the aid Product from the AGAUR agency of the Generalitat de Catalunya. They will study two molecules that act on the immune system as possible treatments for autoimmune diseases.
The lack of interaction between two neuronal receptors is a determining factor in schizophrenia
The interaction of these two receptors leads to the inhibition of the dopaminergic pathway, which in this disorder is abnormally active. This discovery opens the door to the design of new drugs for the treatment of schizophrenia that acts on this interaction.
IDIBELL receives european funding to promote open science and innovation
The project aims to create online courses that help pre-doctoral researchers to acquire transversal skills for the future of their careers.
Blood concentrations of polyphenols are not clearly related to the risk of thyroid cancer
Although polyphenols have shown anticarcinogenic activity in previous in vitro studies, the epidemiological study led by IDIBELL and the ICO has found no association between their concentration in blood and thyroid cancer.
Researchers identify connection patterns in the brain that indicate the risk of developing obsessive disorders in children
A group of researchers from IDIBELL, CIBERSAM and the Hospital de Bellvitge have identified changes in the connection between the frontal cortex and subcortical regions in girls and boys with mild symptoms of obsessive-compulsive disorder (OCD).
Study supports use of the nutrition label Nutri-Score to encourage healthier food choices
Results could inform discussions on food packaging labels across Europe, say researchers. The study has the participation of Antonio Agudo and has been published in the journal The BMJ.
TP53 proposed as a predisposing gene for colon cancer
Until now, TP53 mutations had been associated with a syndrome with a high risk of developing cancer that did not include colorectal tumors.
Presented a program capable of automatically detecting neurodegeneration biomarkers through magnetic resonance imaging
This tool is able to identify single-person neurodegeneration before the symptom’s appearance, which could significate a more effective and personalized medicine.
The Administration of chemo-immunotherapy before lung cancer surgery could improve its prognosis and significantly reduce tumor volume
A study has evaluated the efficacy and safety of the combination of 3 cycles of chemotherapy with immunotherapy before surgery, in 51 patients with locally advanced lung cancer, followed by one year of treatment with immunotherapy.